Imbalance: breaking DNA to destroy cancer cells
Dr. Kevin Mills, a former researcher at The Jackson Laboratory and co-founder of Cyteir Therapeutics, presented a seminar on February 29th regarding the therapeutic role of genomic instability. His research at Cyteir Therapeutics focuses on two small molecules, AID and RAD51, which are involved in genomic damage and genomic repair, … Continue reading